DailyFinance: For Genzyme Corp (GENZ), this year seems to have been plagued with one piece of bad news after another. On Wednesday, the biotechnology company announced that it was dropping development of its experimental kidney disease drug after it failed to show ... Read more
DailyFinance: It seems that when it comes to Aranesp, its blockbuster anemia drug, Amgen (AMGN) just can't catch a break, nor for that matter, create one. Recently, Amgen was hit with a double whammy -- a lawsuit and an unfavorable study of the drug. On Tuesday, ... Read more
Question-and-Answer Session Operator Operator Instructions. Your first question comes from the line of Ted Tenthoff with Piper Jaffray. Ted Tenthoff – Piper Jaffray Tom, you touched on this a little bit on the call, but what actually still has to be done in preparation of the NDA...
The scariest wrinkle in the Omnicare kickback case is just how vulnerable old people in nursing homes are to schemes in which drug companies allegedly induce pharmacies to prescribe drugs they otherwise wouldn't. One patient cited by the government's complaint received 67 -- sixty-seven! -- different drugs under Omnicare's "care."...
The scariest wrinkle in the Omnicare kickback case is just how vulnerable old people in nursing homes are to schemes in which drug companies allegedly induce pharmacies to prescribe drugs they otherwise wouldn't. One patient cited by the government's complaint received 67 -- sixty-seven! -- different drugs under Omnicare's "care."...
BloggingStocks: Bernie Madoff is getting used to his new neighbors. Gone are the days of Montauk and Manhattan, and he isn't sharing his space with topless dancers.
Now, he says goodnight to a drug pusher, chills with a former mobster, and hangs with a convicted ... Read more
BloggingStocks: When Purdue Pharma introduced its pain killer OxyContin to the market back in 1997 the drug was hailed as a savior for seriously ill patients. Unfortunately, what makes the drug so effective also makes it highly addictive, and easily abused. Purdue ... Read more
The major indices closed on their highs for the week ending Friday July 24th. The big week was propelled by the failure of the Obama administrative to get new health care legislation passed before the August recess.
On Friday the Dow 30 Industrials composite was led by the three drug stock components, Merck, (NYSE:MRK), Pfizer, (NYSE:PFE) [...]